| |
| |
|
| Insider
Information: |
Guggenhime Andrew |
| Relationship: |
|
| City: |
San Jose |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
108,934 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$32,740 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
108,934 |
|
|
| Total
Value |
$32,740 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PDL Biopharma Inc |
PDLI |
SVP & Chief Financial ... |
2008-12-18 |
13,255 |
2006-04-03 |
0 |
Premium* |
|
|
Vaxcyte, Inc. |
PCVX |
|
2024-04-18 |
95,679 |
2021-12-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCVX |
Vaxcyte, Inc. |
PRESIDENT AND CFO |
• – – |
2024-04-18 |
4 |
AS |
$61.24 |
$490,199 |
D/D |
(8,000) |
95,679 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
PRESIDENT AND CFO |
• – – |
2024-04-18 |
4 |
OE |
$5.35 |
$42,800 |
D/D |
8,000 |
103,679 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
PRESIDENT AND CFO |
• – – |
2024-03-18 |
4 |
AS |
$69.00 |
$552,144 |
D/D |
(8,000) |
95,679 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
PRESIDENT AND CFO |
• – – |
2024-03-18 |
4 |
OE |
$5.35 |
$42,800 |
D/D |
8,000 |
103,679 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
PRESIDENT AND CFO |
• – – |
2024-03-02 |
4 |
D |
$71.55 |
$271,532 |
D/D |
(3,795) |
95,679 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
PRESIDENT AND CFO |
• – – |
2024-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
99,474 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
PRESIDENT AND CFO |
• – – |
2024-02-20 |
4 |
AS |
$74.08 |
$596,232 |
D/D |
(8,000) |
79,474 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
PRESIDENT AND CFO |
• – – |
2024-02-20 |
4 |
OE |
$5.35 |
$42,800 |
D/D |
8,000 |
87,474 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
PRESIDENT AND CFO |
• – – |
2024-01-18 |
4 |
AS |
$60.28 |
$485,879 |
D/D |
(8,000) |
79,474 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
PRESIDENT AND CFO |
• – – |
2024-01-18 |
4 |
OE |
$5.35 |
$42,800 |
D/D |
8,000 |
87,474 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2023-12-18 |
4 |
OE |
$5.35 |
$42,800 |
D/D |
8,000 |
87,474 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2023-12-18 |
4 |
AS |
$60.17 |
$481,417 |
D/D |
(8,000) |
79,474 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2023-12-14 |
4 |
AS |
$60.22 |
$843,080 |
D/D |
(14,000) |
79,474 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2023-12-14 |
4 |
OE |
$5.35 |
$74,900 |
D/D |
14,000 |
93,474 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2023-11-20 |
4 |
AS |
$51.12 |
$409,063 |
D/D |
(8,000) |
79,474 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2023-11-20 |
4 |
OE |
$5.35 |
$42,800 |
D/D |
8,000 |
87,474 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2023-10-18 |
4 |
AS |
$45.89 |
$367,300 |
D/D |
(8,000) |
79,474 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2023-10-18 |
4 |
OE |
$5.35 |
$42,800 |
D/D |
8,000 |
87,474 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2023-09-05 |
4 |
D |
$51.00 |
$181,968 |
D/D |
(3,568) |
79,474 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2023-03-02 |
4 |
D |
$41.49 |
$71,653 |
D/D |
(1,727) |
82,002 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
83,729 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2022-12-30 |
4 |
OE |
$5.35 |
$126,747 |
D/D |
23,691 |
61,229 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2022-09-19 |
4 |
OE |
$5.35 |
$16,585 |
D/D |
3,100 |
40,638 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2022-09-19 |
4 |
AS |
$26.02 |
$80,898 |
D/D |
(3,100) |
37,538 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
President and CFO |
• – – |
2022-09-02 |
4 |
D |
$26.38 |
$122,641 |
D/D |
(4,649) |
37,538 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
